BCL2 and chronic myelogenous leukemia, BCR-ABL1 positive: Although in comparison diabetic group, late treatment with WJMSCs-CM and insulin reduced the testicular Bax/Bcl-2 ratio in D-CML and D-INSL groups, this reduction was not significant (Figure 6(c)).